February 6, 2020 • 8:11 AM EST Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International
January 2, 2020 • 8:14 AM EST Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products